(Total Views: 791)
Posted On: 11/17/2020 2:19:47 PM
Post# of 36564
Here's the reply I received...pretty generic, but as Mogs mentioned, it is from an attorney:
Dear (name deleted to protect the moron- ie, me):
Thank you for contacting the U.S. Securities and Exchange Commission (SEC).
We appreciate you sharing your concerns regarding Generex Biotechnology Corp. The SEC’s Office of Investor Education and Advocacy processes many comments from individual investors and others. We keep records of the correspondence we receive in a searchable database that SEC staff may make use of in inspections, examinations, and investigations. In addition, some of the correspondence we receive is referred to other SEC offices and divisions for their review. If they have any questions or wish to respond directly to your comments, they will contact you.
Thank you for communicating your views.
Sincerely,
Trevor Perkins
Attorney
Office of Investor Education and Advocacy
U.S. Securities and Exchange Commission
(800) 732-0330
http://www.sec.gov
www.investor.gov
www.twitter.com/SEC_Investor_Ed
Dear (name deleted to protect the moron- ie, me):
Thank you for contacting the U.S. Securities and Exchange Commission (SEC).
We appreciate you sharing your concerns regarding Generex Biotechnology Corp. The SEC’s Office of Investor Education and Advocacy processes many comments from individual investors and others. We keep records of the correspondence we receive in a searchable database that SEC staff may make use of in inspections, examinations, and investigations. In addition, some of the correspondence we receive is referred to other SEC offices and divisions for their review. If they have any questions or wish to respond directly to your comments, they will contact you.
Thank you for communicating your views.
Sincerely,
Trevor Perkins
Attorney
Office of Investor Education and Advocacy
U.S. Securities and Exchange Commission
(800) 732-0330
http://www.sec.gov
www.investor.gov
www.twitter.com/SEC_Investor_Ed
(3)
(0)
